Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is resistant to both rifampicin (RIF) and isoniazid (INH). Whereas many TB diagnostics detect RIF-resistance, few detect INH-monoresistance, which is common and may increase risk of acquired MDR-TB. Whether inclusion of INH-resistance in a first-...

Descripción completa

Detalles Bibliográficos
Autores principales: Denkinger, Claudia M., Pai, Madhukar, Dowdy, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880287/
https://www.ncbi.nlm.nih.gov/pubmed/24404155
http://dx.doi.org/10.1371/journal.pone.0084197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880287/
https://www.ncbi.nlm.nih.gov/pubmed/24404155
http://dx.doi.org/10.1371/journal.pone.0084197

Ejemplares similares